long-term effects of glp-1 receptor agonists GI Adverse Glucagon-Like Peptide-1 GLP-1RA in Different HFpEF Phenotypes
Description
A study utilizing a national database found that individuals treated with GLP-1 receptor agonists had a significantly lower risk of developing glaucoma compared to those who were not on these medications
One-to-one coaching Sign up to access insurance-covered video calls to work with a glucose expert: a personal registered dietitian or certified nutritionist who will help tailor your lifestyle and diet to your goals
Dosing & Administration: Exenatide BID required some patient commitment an injection twice a day using a pen injector , and timing it before meals
Trials 2019
Sean Hashmi, MD Medical Reviewer Sean Hashmi, MD, is an experienced nephrologist and obesity medicine specialist based in Southern California
By week 24 (month 6), trial participants averaged 17.3% total weight loss
